ICI Pakistan Limited takes immense pride in manufacturing, marketing & distributing some of the leading pharmaceutical products available today, including drugs that fight life-threatening diseases. Our strong portfolio of prominent and innovative prescription medicines includes products from internationally renowned pharmaceutical and healthcare partners such as AstraZeneca and Ferrer. We also market our brands; our production capability allows us to manufacture our own high-quality pharmaceuticals and nutraceuticals.

ICI Pharmaceuticals is transforming to become a customer-centric business to foster a positive customer experience at every stage of its decision journey. The marketing strategy has been built on three foundational pillars: Patient/Community Awareness, Advocacy Mobilization, and Scientific Cascades. The focus is on building relationships and delivering value as, when, and how the customer wants it. The business’s journey to move from a single to multichannel approach is another step in this direction.

ICIP Portfolio

Specialty Care:

  • Cardio Care
  • Onco Care
  • Cardio-Metabolic Care
  • Critical Care

Primary Care:

  • Pain & Gastro Care
  • Paeds Care
  • Nutra Care
  • Gynae Care
  • Pulmo Care


ICI Pakistan Limited (“ICI Pakistan”) and AstraZeneca UK Limited (“AstraZeneca”) confirmed the renewal of their longstanding relationship in the cardiovascular and oncology segment. AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialization of prescription medicines, primarily for the treatment of diseases in three therapy areas – Oncology, Cardiovascular and Respiratory. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.

ICI Pakistan also has exclusive rights to market premium Cardiology products from Ferrer of Spain.

Contact Details

Hassan Iqbal 
Distribution & Sales Operation Manager
Mobile: 0092 322 3778815

Najmuddin Alam
Business Development Manager
Mobile: 0092 301 8480812